{"id":46293,"date":"2022-07-18T23:02:22","date_gmt":"2022-07-18T21:02:22","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/"},"modified":"2022-07-18T23:02:22","modified_gmt":"2022-07-18T21:02:22","slug":"johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/","title":{"rendered":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022"},"content":{"rendered":"
\n

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2022 of $1.13 per share on the company\u2019s common stock. The dividend is payable on September 6, 2022 to shareholders of record at the close of business on August 23, 2022. The ex-dividend date is August 22, 2022.\n<\/p>\n

<\/a><\/p>\n

\nAbout Johnson & Johnson<\/span>\n<\/p>\n

\nAt Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That\u2019s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world\u2019s largest and most broadly-based health care company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPress:<\/b>
Jake Sargent
\n
jsargen3@ITS.JNJ.com<\/a>\n<\/p>\n

\nInvestors:<\/b>
Jessica Moore
\n
jmoore29@its.jnj.com<\/a>\n<\/p>\n

\nSarah Wood
\n
swood15@its.jnj.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2022 of $1.13 per share on the company\u2019s common stock. The dividend is payable on September 6, 2022 to shareholders of record at the close of business on August 23, 2022. The … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46293","6":"format-standard","7":"category-industry"},"yoast_head":"\nJohnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2022 of $1.13 per share on the company\u2019s common stock. The dividend is payable on September 6, 2022 to shareholders of record at the close of business on August 23, 2022. The ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-18T21:02:22+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022\",\"datePublished\":\"2022-07-18T21:02:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/\"},\"wordCount\":196,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220718005805\\\/en\\\/1516834\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/\",\"name\":\"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220718005805\\\/en\\\/1516834\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"datePublished\":\"2022-07-18T21:02:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220718005805\\\/en\\\/1516834\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220718005805\\\/en\\\/1516834\\\/21\\\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/","og_locale":"en_US","og_type":"article","og_title":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend","og_description":"NEW BRUNSWICK, N.J.–(BUSINESS WIRE)–Johnson & Johnson today announced that its Board of Directors has declared a cash dividend for the third quarter of 2022 of $1.13 per share on the company\u2019s common stock. The dividend is payable on September 6, 2022 to shareholders of record at the close of business on August 23, 2022. The ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-18T21:02:22+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022","datePublished":"2022-07-18T21:02:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/"},"wordCount":196,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/","url":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/","name":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","datePublished":"2022-07-18T21:02:22+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220718005805\/en\/1516834\/21\/JJ_Logo_Signature_RGB_Red_JPG_JJLogoSignatureRGB_Red.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46293","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46293"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46293\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46293"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46293"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46293"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}